A new tool for the paediatric HIV research: General data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe)

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  de Jose, Ma Isabel ^a   Jiménez de Ory, Santiago ^b   Espiau, Maria ^c   Fortuny, Claudia ^d   Navarro, Ma Luisa ^e   Soler Palacín, Pere ^c   Muñoz Fernandez, Ma Angeles ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL SANT JOAN DE DÉU   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

HIV paediatric cohort; Paediatric HIV infection; Spanish HIV HGM biobank

Indexed keywords

ACCESS TO INFORMATION; CLINICAL RESEARCH; DOCTOR PATIENT RELATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PATIENT INFORMATION; PATIENT TRANSPORT; PROFESSIONAL KNOWLEDGE; SPAIN;

ADULT; BIOMEDICAL RESEARCH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; SPAIN; VIRAL LOAD;

EID: 84871709580     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-2     Document Type: Letter

References (44)

1. Palladino C, Bellon JM, Perez-Hoyos S, Resino R, Guillen S, Garcia D, Gurbindo MD, Ramos JT, de Jose MI, Mellado MJ, et al. Spatial pattern of HIV-1 mother-to-child-transmission in Madrid (Spain) from 1980 till now: demographic and socioeconomic factors. AIDS 2008, 22(16):2199-2205. 10.1097/QAD.0b013e328310fa96, 18832883.
2. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA). AIDS 1998, 12(4):1-8. 3401021, 9456249.
3. Children born to women with HIV-1 infection: natural history and risk of transmission. European Collaborative Study. Lancet 1991, 337(8736):253-260.
4. Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003, 362(9396):1605-1611.
5. Judd A. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. AIDS 2011, 25(18):2279-2287. 3433031, 21971357.
6. McGrath CJ, Chung MH, Richardson BA, Benki-Nugent S, Warui D, John-Stewart GC. Younger age at HAART initiation is associated with more rapid growth reconstitution. AIDS 2011, 25(3):345-355. 10.1097/QAD.0b013e32834171db, 3380084, 21102302.
7. Resino S, Resino R, Maria Bellon J, Micheloud D, Gutierrez MD, de Jose MI, Ramos JT, Fontelos PM, Ciria L, Munoz-Fernandez MA. Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children. Clin Infect Dis 2006, 43(2):243-252. 10.1086/505213, 16779753.
8. Palladino C, Briz V, Policarpo SN, Silveira LF, de Jose MI, Gonzalez-Tome MI, Moreno D, Leon Leal JA, Mellado MJ, de Ory SJ, et al. Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J 29(6):563-566.
9. Saez-Llorens X, Violari A, Ndiweni D, Yogev R, Cashat M, Wiznia A, Chittick G, Harris J, Hinkle J, Blum MR, et al. Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects. Pediatrics 2008, 121(4):e827-835. 10.1542/peds.2006-3078, 18332076.
10. Resino S, Gurbindo D, Cano JM, Sanchez-Ramon S, Muñoz-Fernandez MA. Predictive markers of clinical outcome in vertically HIV-1-infected infants. A prospective longitudinal study. Pediatr Res 2000, 47(4 Pt 1):509-515.
11. Sanchez-Ramon S, Bellon JM, Resino S, Canto-Nogues C, Gurbindo D, Ramos JT, Munoz-Fernandez MA. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. Pediatrics 2003, 111(2):E168-175. 10.1542/peds.111.2.e168, 12563091.
12. Gurbindo D, Resino S, Sanchez-Ramon S, Leon JA, Munoz-Fernandez MA. Correlation of viral load and CD8 T-lymphocytes with development of neurological manifestations in vertically HIV-1-infected infants. A prospective longitudinal study. Neuropediatrics 1999, 30(4):197-204. 10.1055/s-2007-973490, 10569211.
13. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.August 11 p-Aa
14. Ramos JT, de Jose MI, Polo R, Fortuny C, Mellado MJ, Munoz-Fernandez MA, Beceiro J, Bertran JM, Calvo C, Chamorro L, et al. [Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers]. Enferm Infecc Microbiol Clin 2005, 23(5):279-312. 10.1157/13074970, 15899180.
15. Ley 15/1999 ddD, de Protección de datos de caracter personal. BOE N8 298 43088-43099.
16. Garcia-Merino I, de Las Cuevas N, Jimenez JL, Garcia A, Gallego J, Gomez C, Garcia D, Munoz-Fernandez MA. Pediatric HIV BioBank: a new role of the Spanish HIV BioBank in pediatric HIV research. AIDS Res Hum Retroviruses 26(2):241-244.
17. Garcia-Merino I, de Las Cuevas N, Jimenez JL, Gallego J, Gomez C, Prieto C, Serramia MJ, Lorente R, Munoz-Fernandez MA. The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology 2009, 6:27. 10.1186/1742-4690-6-27, 2667474, 19272145.
18. Nso AP, Larru B, Bellon JM, Mellado MJ, Ramos JT, Gonzalez MI, Navarro ML, Munoz-Fernandez MA, Jose MI. HIV-infected adolescents: relationship between atazanavir plasma levels and bilirubin concentrations. J Adolesc Health 48(1):100-102.
19. Red RIS web site In http://www.retic-ris.net; Accessed February 29.
20. Maturo D, Powell A, Major-Wilson H, Sanchez K, De Santis JP, Friedman LB. Development of a protocol for transitioning adolescents with HIV infection to adult care. J Pediatr Health Care 2011, 25(1):16-23. 10.1016/j.pedhc.2009.12.005, 21147403.
21. Abadi J. Transitioning HIV-infected adolescents into adult care 2011, http://www.medscape.com/viewarticle/748356.
22. Centers for Disease Control and Prevention Fact sheet: HIV/AIDS among youth 2008, http://www.cdc.gov/hiv/resources/factsheets/PDF/youth.htm, Centers for Disease Control and Prevention.
23. Freed GL, Hudson EJ. Transitioning children with chronic diseases to adult care: current knowledge, practices, and directions. J Pediatr 2006, 148(6):824-827. 10.1016/j.jpeds.2006.02.010, 16769396.
24. Lewis-Gary MD. Transitioning to adult health care facilities for young adults with a chronic condition. Pediatr Nurs 2001, 27(5):521-524.
25. Por J, Golberg B, Lennox V, Burr P, Barrow J, Dennard L. Transition of care: health care professionals' view. J Nurs Manag 2004, 12(5):354-361. 10.1111/j.1365-2834.2004.00428.x, 15315492.
26. Lotstein DS, McPherson M, Strickland B, Newacheck PW. Transition planning for youth with special health care needs: results from the National Survey of Children with Special Health Care Needs. Pediatrics 2005, 115(6):1562-1568. 10.1542/peds.2004-1262, 15930217.
27. Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM. Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. J Adolesc Health 2003, 33(4):309-311. 10.1016/S1054-139X(03)00208-8, 14519573.
28. Flume PA, Taylor LA, Anderson DL, Gray S, Turner D. Transition programs in cystic fibrosis centers: perceptions of team members. Pediatr Pulmonol 2004, 37(1):4-7. 10.1002/ppul.10391, 14679482.
29. Vigano A, Bedogni G, Manfredini V, Giacomet V, Cerini C, di Nello F, Penagini F, Caprio C, Zuccotti GV. Long-term renal safety of tenofovir disoproxil fumarate in vertically HIV-infected children, adolescents and young adults: a 60-month follow-up study. Clin Drug Investig 2011, 31(6):407-415. 10.2165/11590400-000000000-00000, 21528939.
30. Cruz ML, Cardoso CA, Joao EC, Gomes IM, Abreu TF, Oliveira RH, Machado ES, Dias IR, Rubini NM, Succi RM. Pregnancy in HIV vertically infected adolescents and young women: a new generation of HIV-exposed infants. AIDS 2010, 24(17):2727-2731. 10.1097/QAD.0b013e32833e50d4, 20827164.
31. Judd A, Ferrand RA, Jungmann E, Foster C, Masters J, Rice B, Lyall H, Tookey PA, Prime K. Vertically acquired HIV diagnosed in adolescence and early adulthood in the United Kingdom and Ireland: findings from national surveillance. HIV Med 2009, 10(4):253-256. 10.1111/j.1468-1293.2008.00676.x, 19187173.
32. Dunn D, Woodburn P, Duong T, Peto J, Phillips A, Gibb D, Porter K. Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. J Infect Dis 2008, 197(3):398-404. 10.1086/524686, 18248303.
33. Clemente MI, Alvarez S, Serramia MJ, Turriziani O, Genebat M, Leal M, Fresno M, Munoz-Fernandez MA. Non-steroidal anti-inflammatory drugs increase the antiretroviral activity of nucleoside reverse transcriptase inhibitors in HIV type-1-infected T-lymphocytes: role of multidrug resistance protein 4. Antivir Ther 2009, 14(8):1101-1111.
34. Genebat M, Ruiz-Mateos E, Leon JA, Gonzalez-Serna A, Pulido I, Rivas I, Ferrando-Martinez S, Sanchez B, Munoz-Fernandez MA, Leal M. Correlation between the Trofile test and virological response to a short-term maraviroc exposure in HIV-infected patients. J Antimicrob Chemother 2009, 64(4):845-849. 10.1093/jac/dkp293, 19671585.
35. Palladino C, Briz V, Gonzalez-Tome MI, Leon Leal JA, Navarro ML, de Jose MI, Ramos JT, Munoz-Fernandez MA. Short communication: evaluation of the effect of enfuvirtide in 11 HIV-1 vertically infected pediatric patients outside clinical trials. AIDS Res Hum Retroviruses 2010, 26(3):301-305. 10.1089/aid.2009.0151, 20334565.
36. Resino S, Micheloud D, Lorente R, Bellon JM, Navarro ML, Munoz-Fernandez MA. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy. HIV Med 2011, 12(1):54-60. 10.1111/j.1468-1293.2010.00837.x, 20497248.
37. Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, et al. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis 2011, 11(4):273-283. 3111069, 21288774.
38. Palladino C, Climent FJ, Jose MI, Jimenez De Ory S, Bellon JM, Guillen S, Gurbindo MD, Gonzalez-Tome I, Mellado MJ, Martinez Perez J, et al. Causes of death in pediatric patients vertically infected by the human immunodeficiency virus type 1 in Madrid, Spain, from 1982 to mid-2009. Pediatr Infect Dis J 2011, 30(6):495-500.
39. Cambon-Thomsen A, Thorisson GA, Mabile L, Andrieu S, Bertier G, Boeckhout M, Carpenter J, Dagher G, Dalgleish R, Deschenes M, et al. The role of a Bioresource Research Impact Factor as an incentive to share human bioresources. Nat Genet 2011, 43(6):503-504. 10.1038/ng.831, 21614086.
40. de Mulder M, Yebra G, Martin L, Prieto L, Mellado MJ, Rojo P, Jimenez de Ory S, Munoz-Fernandez MA, Ramos JT, Holguin A. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain. J Antimicrob Chemother 2011, 66(10):2362-2371. 10.1093/jac/dkr305, 21810838.
41. Briz V, Palladino C, Navarro M, Jimenez de Ory S, Gonzalez-Tome M, Leon J, Nunez-Cuadros E, de Jose M, Ramos J, Munoz-Fernandez M. Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients. HIV Med 2011, 12(7):442-446. 10.1111/j.1468-1293.2010.00907.x, 21395964.
42. Ferrando-Martinez S, Casazza JP, Leal M, Machmach K, Munoz-Fernandez MA, Viciana P, Koup RA, Ruiz-Mateos E. Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers. J Virol 2012, 86(7):3667-3674. 10.1128/JVI.07034-11, 3302538, 22278254.
43. Soler-Palacin P, Melendo S, Noguera-Julian A, Fortuny C, Navarro ML, Mellado MJ, Garcia L, Uriona S, Martin-Nalda A, Figueras C. Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens. AIDS 2011, 25(2):171-176. 10.1097/QAD.0b013e328340fdca, 21076275.
44. Noguera-Julian A, Provens AC, Soler-Palacin P, Espiau M, Mur A, Mendez M, Fortuny C. Pandemic influenza a (2009 H1N1) in human immunodeficiency virus-infected catalan children. Pediatr Infect Dis J 2011, 30(2):173-175. 10.1097/INF.0b013e3181f5358b, 20802374.